You are here

Prevalence of Depression and Anxiety in Patients Seeking Medical Care at General Health Care Settings in China

Last updated on December 6, 2018

FOR MORE INFORMATION
Study Location
Beijing, Beijing, 100034 China
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Adult
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Greater than or equal to 18 years.

- Consecutive general internal medical outpatients attending the selected general
hospitals in the investigate days(Department of neurology, gastrointestinal,
cardiology and gynecology).

- Informed consent obtained for all patients who will undergo a standardized diagnostic
assessment by specialized psychiatrists.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients who have been screened on a previous visit.

- Patients who are unable to complete the survey because of mental or physical
incapacity.

NCT00478829
Pfizer
Completed
Prevalence of Depression and Anxiety in Patients Seeking Medical Care at General Health Care Settings in China

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.

Similar Trials

Healthy Adult Subjects, Healthy Elderly Subjects
NCT02691702
All Genders
18+
Years
Multiple Sites
Adult Not Younger Than 65 Years
NCT03014206
All Genders
65+
Years
Tokyo,
Healthy Adults
NCT02767089
All Genders
18+
Years
Kalamazoo, Michigan
Prevalence of Depression and Anxiety in Patients Seeking Medical Care at General Health Care Settings in China
Prevalence of Depression and Anxiety in Patients Seeking Medical Care at General Health Care Settings in 5 Large Cities in China

Objectives: Primary: To estimate the prevalence of depression and/or anxiety disorder in outpatients attending the general health care settings in China.

Secondary:

  • To estimate gender- and age-specific prevalence of depression and/or anxiety disorder in outpatients attending the general health care settings in China.
  • To estimate the prevalence of depression and/or anxiety disorder in outpatients attending the general health care settings such as departments of neurology, gastroenterology, cardiology, and gynecology.
  • To describe the recognition and treatment rate by treating physicians as depression and/or anxiety for outpatients in the general health care settings in China.
This study is designed to investigate the status of identifying depression and/or anxiety disorder with somatic symptoms in general hospitals in China. The study will generate valuable information to the medical community; therefore the early and vigorous treatment is possible. It's in line with China government authorities' target to increase the recognition rate of depression and/or anxiety in primary care settings to more than 50% by the end of 2010. The study will also help to identify specific diagnosis and treatment patterns for depressive / anxious patients and their comorbid conditions.
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
Adult
Not Provided
Not Provided
Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
8000
July 2007
Not Provided

Main Inclusion Criteria:

  • Greater than or equal to 18 years.
  • Consecutive general internal medical outpatients attending the selected general hospitals in the investigate days(Department of neurology, gastrointestinal, cardiology and gynecology).
  • Informed consent obtained for all patients who will undergo a standardized diagnostic assessment by specialized psychiatrists.

Main Exclusion Criteria:

  • Patients who have been screened on a previous visit.
  • Patients who are unable to complete the survey because of mental or physical incapacity.
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
China
 
 
NCT00478829
0600B2-4417
Not Provided
Not Provided
Not Provided
Not Provided
Wyeth is now a wholly owned subsidiary of Pfizer
Not Provided
Study Director: Medical Monitor Wyeth is now a wholly owned subsidiary of Pfizer
Principal Investigator: Trial Manager For China, [email protected]
Wyeth is now a wholly owned subsidiary of Pfizer
December 2007

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]



Call Now